Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 872381108 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Nantahala Capital Management, LLC
13G/A
Amendment 3
|
12.9% |
8/14/2026
Event 6/30/2026
|
|
| Nantahala Capital Management, LLC | 12.9% | ||
| Wilmot B. Harkey | 12.9% | ||
| Daniel Mack | 12.9% | ||
|
SilverArc Capital Management, LLC
13G/A
Amendment 2
|
4.8% |
8/14/2026
Event 6/30/2026
|
|
| SilverArc Capital Management, LLC | 4.8% | ||
| Devesh Gandhi | 4.8% | ||
|
SilverArc Capital Management, LLC
13G
|
4.8% |
8/11/2026
Event 6/30/2026
|
|
| SilverArc Capital Management, LLC | 4.8% | ||
| Devesh Gandhi | 4.8% | ||
|
Ew Healthcare Partners Fund 2, L.P.
13D
|
17.2% |
6/9/2026
Event 6/9/2026
|
|
| Ew Healthcare Partners Fund 2, L.P. | 6.8% | ||
| Ew Healthcare Partners Fund 2-A, L.P. | 10.5% | ||
| EW Healthcare Partners Fund 2-GP, L.P. | 17.2% | ||
| EW Healthcare Partners Fund 2-UGP, LLC | 17.2% | ||
| Lytton, Laurence W. 13G/A Amendment 4 | 5.5% |
5/15/2026
Event 3/31/2026
|
|
|
Ew Healthcare Partners Fund 2, L.P.
13G/A
Amendment 2
|
17.3% |
11/17/2025
Event 11/17/2025
|
|
| Ew Healthcare Partners Fund 2, L.P. | 6.8% | ||
| Ew Healthcare Partners Fund 2-A, L.P. | 10.5% | ||
| EW Healthcare Partners Fund 2 GP, L.P. | 17.3% | ||
| EW Healthcare Partners Fund 2-UGP, LLC | 17.3% | ||
| Lytton, Laurence W. 13G/A Amendment 3 | 7.2% |
11/14/2025
Event 9/30/2025
|
|
| Grow Funds, LLC. 13G/A Amendment 1 |
Checked 5% or less
|
10/15/2025
Event 9/30/2025
|
|
| Lytton, Laurence W. 13G/A Amendment 2 | 8.5% |
8/14/2025
Event 6/30/2025
|
|
|
North Run Capital, LP
13G/A
Amendment 1
|
9.3% |
5/30/2025
Event 3/31/2025
|
|
| North Run Capital, LP | 9.3% | ||
| North Run Advisors, LLC | 9.3% | ||
| North Run - Due North Partners, LP | 9.3% | ||
| North Run GP, LP | 9.3% | ||
| Todd B. Hammer | 9.3% | ||
| Thomas B. Ellis | 9.3% | ||
| Michael Bosco | 9.3% | ||
|
North Run Capital, LP
13G
|
5.0% |
5/30/2025
Event 1/24/2025
|
|
| North Run Capital, LP | 5.0% | ||
| North Run Advisors, LLC | 5.0% | ||
| North Run - Due North Partners, LP | 5.0% | ||
| North Run GP, LP | 5.0% | ||
| Todd B. Hammer | 5.0% | ||
| Thomas B. Ellis | 5.0% | ||
| Michael Bosco | 5.0% | ||
|
Orin Hirschman
13G/A
Amendment 4
|
3.6% |
5/8/2025
Event 3/31/2025
|
|
| Orin Hirschman | 3.6% | ||
| AIGH Capital Management LLC | 3.6% | ||
|
Nantahala Capital Management, LLC
13G/A
Amendment 2
|
12.9% |
5/7/2025
Event 4/30/2025
|
|
| Nantahala Capital Management, LLC | 12.9% | ||
| Wilmot B. Harkey | 12.9% | ||
| Daniel Mack | 12.9% | ||
|
Nantahala Capital Management, LLC
13G/A
Amendment 1
|
10.0% |
2/14/2025
Event 12/31/2024
|
|
| Nantahala Capital Management, LLC | 10.0% | ||
| Wilmot B. Harkey | 10.0% | ||
| Daniel Mack | 10.0% | ||
|
Stonepine Capital Management, LLC
13G/A
Amendment 1
|
6.0% |
2/13/2025
Event 12/31/2024
|
|
| Stonepine Capital Management, LLC | 6.0% | ||
| Stonepine Capital, L.P. | 6.0% | ||
| Stonepine GP, LLC | 6.0% | ||
| Jon M. Plexico | 6.0% | ||
|
SilverArc Capital Management, LLC
13G
|
7.8% |
2/12/2025
Event 12/31/2024
|
|
| SilverArc Capital Management, LLC | 7.8% | ||
| Devesh S. Gandhi | 7.8% | ||
|
Orin Hirschman
13G/A
Amendment 3
|
6.8% |
1/31/2025
Event 12/31/2024
|
|
| Orin Hirschman | 6.8% | ||
| AIGH Capital Management LLC | 6.8% | ||
|
Nantahala Capital Management, LLC
13G
|
7.7% |
11/14/2024
Event 9/30/2024
|
|
| Nantahala Capital Management, LLC | 7.7% | ||
| Wilmot B. Harkey | 7.7% | ||
| Daniel Mack | 7.7% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 46 | 31.6 M | $23.7 M |
| 2026 Q1 | 37 | 26.9 M | $16.7 M |
| 2025 Q4 | 43 | 27.6 M | $32.5 M |
| 2025 Q3 | 42 | 23.6 M | $35.1 M |
| 2025 Q2 | 50 | 23.5 M | $45.5 M |
| 2025 Q1 | 54 | 24.6 M | $30.0 M |
| 2024 Q4 | 52 | 27.2 M | $82.0 M |
| 2024 Q3 | 54 | 18.0 M | $45.6 M |
| 2024 Q2 | 74 | 22.3 M | $105 M |
| 2024 Q1 | 64 | 20.8 M | $118 M |
| 2023 Q4 | 64 | 22.2 M | $147 M |
| 2023 Q3 | 71 | 21.9 M | $175 M |
| 2023 Q2 | 70 | 22.1 M | $223 M |
| 2023 Q1 | 57 | 16.9 M | $180 M |
| 2022 Q4 | 51 | 17.5 M | $201 M |
| 2022 Q3 | 46 | 16.8 M | $143 M |
| 2022 Q2 | 33 | 13.5 M | $95.0 M |
| 2022 Q1 | 31 | 11.2 M | $130 M |
| 2021 Q4 | 38 | 10.6 M | $135 M |
| 2021 Q3 | 38 | 10.2 M | $140 M |
| 2021 Q2 | 46 | 10.2 M | $165 M |
| 2021 Q1 | 48 | 9.89 M | $147 M |
| 2020 Q4 | 48 | 9.69 M | $146 M |
| 2020 Q3 | 45 | 9.75 M | $161 M |
| 2020 Q2 | 51 | 9.89 M | $128 M |
| 2020 Q1 | 31 | 6.50 M | $50.7 M |
| 2019 Q4 | 24 | 6.41 M | $83.0 M |